These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 6273102

  • 1. Effect of glutathione and uridine 5'-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the Salmonella/microsome assay.
    Malaveille C, Brun G, Hautefeuille A, Bartsch H.
    Dev Toxicol Environ Sci; 1980; 8():175-80. PubMed ID: 6273102
    [No Abstract] [Full Text] [Related]

  • 2. Effect of glutathione and uridine 5'-diphosphoglucuronic acid on mutagenesis by benzo[a]pyrene and aflatoxin B1 in the Salmonella/microsome assay.
    Malaveille C, Brun G, Hautefeuille A, Bartsch H.
    Mutat Res; 1981 Aug; 83(1):15-24. PubMed ID: 6268971
    [Abstract] [Full Text] [Related]

  • 3. Modification of benzo(a)pyrene metabolism with microsomes by addition of uridine 5'-diphosphoglucuronic acid.
    Nemoto N, Takayama S.
    Cancer Res; 1977 Nov; 37(11):4125-9. PubMed ID: 908046
    [Abstract] [Full Text] [Related]

  • 4. Effect of glutathione and uridine-5'-diphosphoglucuronic acid on the mutagenicity of tryptophan pyrolysis products (Trp-P-1 and Trp-P-2) by rat-liver and -intestine S9 fraction.
    de Waziers I, Decloître F.
    Mutat Res; 1984 Jan; 139(1):15-9. PubMed ID: 6419097
    [Abstract] [Full Text] [Related]

  • 5. [Mutagenic action of benz(a)pyrene and its metabolites in the in vitro Salmonella typhimurium-microsomes test system].
    Tolcheev IuD, Khitrovo IA, Kobliakov VA.
    Biull Eksp Biol Med; 1980 Aug; 90(8):208-10. PubMed ID: 6996763
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of benzo(a)pyrene and benzo(a)pyrene 7,8-dihydrodiol metabolism by benzo(a)pyrene quinones.
    Shen AL, Fahl WE, Wrighton SA, Jefcoate CR.
    Cancer Res; 1979 Oct; 39(10):4123-9. PubMed ID: 113086
    [No Abstract] [Full Text] [Related]

  • 7. Kinetic determinants of benzo[a]pyrene metabolism to dihydrodiol epoxides by 3-methylcholanthrene-induced rat liver microsomes.
    Keller GM, Turner CR, Jefcoate CR.
    Mol Pharmacol; 1982 Sep; 22(2):451-8. PubMed ID: 6292697
    [No Abstract] [Full Text] [Related]

  • 8. Kinetics of benzo[a]pyrene induced mutagenesis in a highly sensitive salmonella/microsome assay.
    Unger J, Guttenplan JB.
    Mutat Res; 1980 Mar; 77(3):221-8. PubMed ID: 6991920
    [Abstract] [Full Text] [Related]

  • 9. Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
    Golan MD, Bücker M, Schmassmann HU, Raphael D, Jung R, Bindel U, Brase HO, Tegtmeyer F, Friedberg T, Lorenz J, Stasiecki P, Oesch F.
    Drug Metab Dispos; 1980 Mar; 8(3):121-6. PubMed ID: 6104571
    [No Abstract] [Full Text] [Related]

  • 10. Synergistic, additive, and antagonistic mutagenic responses to binary mixtures of benzo(a)pyrene and benzo(e)pyrene as detected by strains TA98 and TA100 in the Salmonella/microsome assay.
    Hass BS, Brooks EE, Schumann KE, Dornfeld SS.
    Environ Mutagen; 1981 Mar; 3(2):159-66. PubMed ID: 6263605
    [Abstract] [Full Text] [Related]

  • 11. Presentation of benzo(a)pyrene to microsomal enzymes by asbestos fibers in the Salmonella/mammalian microsome mutagenicity test.
    Szyba K, Lange A.
    Environ Health Perspect; 1983 Sep; 51():337-41. PubMed ID: 6315376
    [Abstract] [Full Text] [Related]

  • 12. The metabolic activation of benzo(a)pyrene and 9-hydroxybenzo(a)pyrene by liver microsomal fractions.
    Lubet RA, Capdevila J, Prough RA.
    Int J Cancer; 1979 Mar 15; 23(3):353-7. PubMed ID: 374283
    [Abstract] [Full Text] [Related]

  • 13. Effect of UDP-glucuronic acid on the microsome-mediated binding of benzo(a)pyrene metabolites to calf thymus DNA.
    Nemoto N, Hirakawa T, Takayama S.
    Carcinogenesis; 1980 Feb 15; 1(2):115-20. PubMed ID: 22282989
    [Abstract] [Full Text] [Related]

  • 14. Proceedings: Influence of epoxide hydrase inhibitors on mutagenic effects of reactive metabolites generated in situ from benzo(a)pyrene.
    Glatt HR, Oesch F.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Feb 15; 282(Suppl):suppl 282:R24. PubMed ID: 4152359
    [No Abstract] [Full Text] [Related]

  • 15. Comparative benzo[a]pyrene metabolite patterns in fish and rodents.
    Melius P.
    Natl Cancer Inst Monogr; 1984 May 15; 65():387-90. PubMed ID: 6087145
    [Abstract] [Full Text] [Related]

  • 16. The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity.
    Lake BG, Rowland IR, Harris RA, Collins MA, Phillips JC, Cottrell RC, Gangolli SD.
    Adv Exp Med Biol; 1981 May 15; 136 Pt B():1143-7. PubMed ID: 6283820
    [No Abstract] [Full Text] [Related]

  • 17. Mixtures of polycyclic aromatic compounds inhibit mutagenesis in the Salmonella/microsome assay by inhibition of metabolic activation.
    Haugen DA, Peak MJ.
    Mutat Res; 1983 Mar 15; 116(3-4):257-69. PubMed ID: 6300671
    [Abstract] [Full Text] [Related]

  • 18. Mutagenicity of some methylated benzo[a]pyrene derivatives.
    Santella R, Kinoshita T, Jeffrey AM.
    Mutat Res; 1982 Mar 15; 104(4-5):209-13. PubMed ID: 6287248
    [Abstract] [Full Text] [Related]

  • 19. Structural requirements for the metabolic activation of benzo[a]pyrene to mutagenic products: effects of modifications in the 4,5-, 7,8-, and 9,10-positions.
    Wood AW, Levin W, Lu AY, Ryan D, West SB, Yagi H, Mah HD, Jerina DM, Conney AH.
    Mol Pharmacol; 1977 Nov 15; 13(6):1116-25. PubMed ID: 339055
    [No Abstract] [Full Text] [Related]

  • 20. Enzymatic conjugation of benzo (a) pyrene oxides, phenols and dihydrodiols with UDP-glucuronic acid.
    Nemoto N, Gelboin HV.
    Biochem Pharmacol; 1976 May 15; 25(10):1221-6. PubMed ID: 938546
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.